Literature DB >> 28938429

Effect of Preconception Impaired Glucose Tolerance on Pregnancy Outcomes in Women With Polycystic Ovary Syndrome.

Daimin Wei1,2,3, Bo Zhang4, Yuhua Shi1,2,3, Lin Zhang1,2,3, Shigang Zhao1,2,3, Yanzhi Du5, Lizhen Xu5, Richard S Legro6, Heping Zhang7, Zi-Jiang Chen1,2,3.   

Abstract

Context: Women with polycystic ovary syndrome (PCOS) commonly have intrinsic insulin resistance and are recommended to undergo an oral glucose tolerance test (OGTT) for diabetes screening. However, the effect of preconception impaired glucose tolerance (IGT) on pregnancy is still unclear. Objective: To prospectively assess the effect of preconception IGT on pregnancy outcomes. Design, Setting, Patients, Interventions, and Main Outcome Measures: This was a secondary analysis of a multicenter randomized trial in 1508 women with PCOS comparing live birth and obstetric complications between fresh and frozen embryo transfer. At baseline, fasting and 2-hour glucose and insulin levels after 75-g OGTT were measured.
Results: Women with preconception IGT had higher risks of gestational diabetes in both singleton pregnancy [9.5% vs 3.2%; odds ratio (OR) 3.13; 95% confidence interval (CI) 1.23to 7.69] and twin pregnancy (20.0% vs 3.2%; OR 7.69; 95% CI 2.78 to 20.00) than women with normoglycemia. Preconception IGT was associated with a higher risk of large for gestational age in singleton newborns compared with normoglycemia (34.7% vs 19.8%; OR 2.13; 95% CI 1.19 to 3.85) or isolated impaired fasting glucose (i-IFG) (34.7% vs 15.4%; OR 2.94; 95% CI 1.33 to 6.25). Women with preconception IGT had a higher singleton pregnancy loss rate than women with i-IFG (31.4% vs 17.5%; OR 2.17; 95% CI 1.11 to 4.17). After adjusting for age, body mass index, duration of infertility, total testosterone level, and treatment groups (frozen vs fresh embryo transfer), these associations remained. Conclusions: Preconception IGT, independent from BMI, was associated with adverse pregnancy outcome compared with i-IFG and normoglycemia.
Copyright © 2017 Endocrine Society

Entities:  

Mesh:

Year:  2017        PMID: 28938429     DOI: 10.1210/jc.2017-01294

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

1.  Metabolic Syndrome and the Effectiveness of Low-dose Aspirin on Reproductive Outcomes.

Authors:  Carrie J Nobles; Pauline Mendola; Sunni L Mumford; Keewan Kim; Lindsey Sjaarda; Micah Hill; Robert M Silver; Ashley I Naimi; Neil J Perkins; Enrique F Schisterman
Journal:  Epidemiology       Date:  2019-07       Impact factor: 4.822

2.  Afamin predicts gestational diabetes in polycystic ovary syndrome patients preconceptionally.

Authors:  Angela Köninger; Antonella Iannaccone; Ensar Hajder; Mirjam Frank; Boerge Schmidt; Ekkehard Schleussner; Rainer Kimmig; Alexandra Gellhaus; Hans Dieplinger
Journal:  Endocr Connect       Date:  2019-05-01       Impact factor: 3.335

3.  Influence of b2 adrenergic receptor polymorphism (rs1042713 and rs1042714) on anthropometric, hormonal and lipid profiles in polycystic ovarian syndrome.

Authors:  Maha H Daghestani; Maha Omair; Mazin Daghestani; Sonya S Abdel-Razeq; Namik Kaya; Arjumand Warsy
Journal:  J Med Biochem       Date:  2021-01-26       Impact factor: 3.402

4.  Effect of Hyperinsulinemia and Insulin Resistance on Endocrine, Metabolic, and Reproductive Outcomes in Non-PCOS Women Undergoing Assisted Reproduction: A Retrospective Cohort Study.

Authors:  Wang-Yu Cai; Xi Luo; Jianyuan Song; Danpin Ji; Jun Zhu; Cuicui Duan; Wei Wu; Xiao-Ke Wu; Jian Xu
Journal:  Front Med (Lausanne)       Date:  2022-01-07

5.  Preconception hemoglobin A1c concentration in healthy women is not associated with fecundability or pregnancy loss.

Authors:  Jessica R Zolton; Lindsey A Sjaarda; Sunni L Mumford; Tiffany L Holland; Keewan Kim; Kerry S Flannagan; Samrawit F Yisahak; Stefanie N Hinkle; Matthew T Connell; Mark V White; Neil J Perkins; Robert M Silver; Micah J Hill; Alan H DeCherney; Enrique F Schisterman
Journal:  F S Rep       Date:  2022-01-20

6.  Differences in lipid metabolism in acquired versus preexisting glucose intolerance during gestation: role of free fatty acids and sphingosine-1-phosphate.

Authors:  Moritz Liebmann; Katharina Grupe; Melissa Asuaje Pfeifer; Ingo Rustenbeck; Stephan Scherneck
Journal:  Lipids Health Dis       Date:  2022-10-08       Impact factor: 4.315

7.  Metabolic changes during pregnancy in glucose-intolerant NZO mice: A polygenic model with prediabetic metabolism.

Authors:  Katharina Grupe; Melissa Asuaje Pfeifer; Franziska Dannehl; Moritz Liebmann; Ingo Rustenbeck; Annette Schürmann; Stephan Scherneck
Journal:  Physiol Rep       Date:  2020-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.